Singapore legislation

Regulation 14

Complete exemption of persons dealing with certain poisons

Amended byS 562/2022 wef 01/08/2022S 834/2023 wef 18/12/2023S 834/2023 wef 18/12/2023S 562/2022 wef 01/08/2022S 834/2023 wef 18/12/2023S 834/2023 wef 18/12/2023

Subregulation 1

Amended byS 562/2022 wef 01/08/2022S 834/2023 wef 18/12/2023S 834/2023 wef 18/12/2023S 562/2022 wef 01/08/2022S 834/2023 wef 18/12/2023

Nothing in the Act or these Rules applies to —

(a)

a person who deals with or possesses —

(i)

any article specified in Group I of the Second Schedule; or

(ii)

any poison specified in the first or second column of Group II of the Second Schedule when contained in or consisting of the article or substance specified opposite that poison in the third column;

(b)

a public officer or an officer of the Authority who imports any poison on account of the Government in the course of that officer’s duty;

(c)

a holder of a manufacturer’s licence for a health product under the Health Products Act 2007 who imports a substance specified in the First Schedule, if that substance is required for the manufacture of the health product; or

(d)

a holder of a manufacturer’s licence for an active ingredient who imports a substance specified in the First Schedule, if that substance is required for the manufacture of the active ingredient.

Subregulation 2

Amended byS 834/2023 wef 18/12/2023

In paragraph (1) —

Definition

“active ingredient” means any substance or compound that is usable in the manufacture of a health product under the Health Products Act 2007 as a pharmacologically active constituent;

Definition

“manufacturer’s licence for an active ingredient” means a licence authorising the holder of the licence to manufacture any active ingredient under the Health Products (Active Ingredients) Regulations 2023.

Amended byS 834/2023 wef 18/12/2023

Read in full context — Poisons Rules →